Search research articles
Contact Us
Filters
Showing results (1-10 of 213) with videos related to
Page
of 22
Sort By:
CNS Drugs
|
June 2, 2009
Prescription of heroin for the management of heroin dependence: current status
Nicholas Lintzeris
Drug and Alcohol Review
|
August 22, 2002
Buprenorphine dosing regime in the management of out-patient heroin withdrawal
Nicholas Lintzeris
Addiction (Abingdon, England)
|
January 19, 2010
Commentary on Blanken et al. (2010): long-term heroin-assisted treatment-some more questions and answers
Nicholas Lintzeris
Addiction (Abingdon, England)
|
March 19, 2013
Commentary on Minozzi et al. (2013): diagnosing opioid dependence in the context of long-term opioid use for chronic pain-counting shades of grey in a black and white world
Nicholas Lintzeris
The Medical Journal of Australia
|
March 25, 2020
Providing take home naloxone needs to be improved to prevent opioid overdose deaths
Nicholas Lintzeris
Journal of Substance Abuse Treatment
|
December 11, 2020
Depot buprenorphine during COVID-19 in Australia: Opportunities and challenges
Shalini Arunogiri, Nicholas Lintzeris
The American Journal on Addictions
|
February 6, 2010
Benzodiazepines, methadone and buprenorphine: interactions and clinical management
Nicholas Lintzeris, Suzanne Nielsen
Addiction (Abingdon, England)
|
May 28, 2009
The use of sublingual buprenorphine-naloxone for reversing heroin overdose: a high-risk strategy that should not be recommended
Suzanne Nielsen, Nicholas Lintzeris
Pain Management
|
September 2, 2025
Buvidal/Brixadi - a long-acting injectable buprenorphine formulation for the treatment of opioid dependence
Nicholas Lintzeris, Adrian J Dunlop
The Medical Journal of Australia
|
December 17, 2011
The health impacts of khat: a qualitative study among Somali-Australians
Heather Douglas, Merali Boyle, Nicholas Lintzeris
Page
of 22
Search research articles
Search
Showing results (1-10 of 213) with videos related to
Sort By:
Page
of 22
CNS Drugs
|
June 2, 2009
Prescription of heroin for the management of heroin dependence: current status
Nicholas Lintzeris
Drug and Alcohol Review
|
August 22, 2002
Buprenorphine dosing regime in the management of out-patient heroin withdrawal
Nicholas Lintzeris
Addiction (Abingdon, England)
|
January 19, 2010
Commentary on Blanken et al. (2010): long-term heroin-assisted treatment-some more questions and answers
Nicholas Lintzeris
Addiction (Abingdon, England)
|
March 19, 2013
Commentary on Minozzi et al. (2013): diagnosing opioid dependence in the context of long-term opioid use for chronic pain-counting shades of grey in a black and white world
Nicholas Lintzeris
The Medical Journal of Australia
|
March 25, 2020
Providing take home naloxone needs to be improved to prevent opioid overdose deaths
Nicholas Lintzeris
Journal of Substance Abuse Treatment
|
December 11, 2020
Depot buprenorphine during COVID-19 in Australia: Opportunities and challenges
Shalini Arunogiri, Nicholas Lintzeris
The American Journal on Addictions
|
February 6, 2010
Benzodiazepines, methadone and buprenorphine: interactions and clinical management
Nicholas Lintzeris, Suzanne Nielsen
Addiction (Abingdon, England)
|
May 28, 2009
The use of sublingual buprenorphine-naloxone for reversing heroin overdose: a high-risk strategy that should not be recommended
Suzanne Nielsen, Nicholas Lintzeris
Pain Management
|
September 2, 2025
Buvidal/Brixadi - a long-acting injectable buprenorphine formulation for the treatment of opioid dependence
Nicholas Lintzeris, Adrian J Dunlop
The Medical Journal of Australia
|
December 17, 2011
The health impacts of khat: a qualitative study among Somali-Australians
Heather Douglas, Merali Boyle, Nicholas Lintzeris
Page
of 22